Skip to content
  • Facebook
  • Twitter
  • Instagram
  • Email
NEWSX 360 : The Global News Platform

NEWSX 360 : The Global News Platform

News from across the Globe

  • Home
  • About Us
  • Terms & Conditions
  • Contact Us
  • Editor’s Note
  • Privacy Policy
  • Toggle search form
  • Dynamic Cables Reports Highest Ever Quarterly Revenue News
  • 13 year old Aum Agrahari is giving competition to famous singers of Bollywood News
  • Industry Leaders Unite to Tackle Environmental Challenges in Wilo Sustainability Conclave News
  • 101 Music Gujju Chappan Ni Chhati, Chelchabilo Declared Navratri Anthem by Grooving Revellers News
  • bauma CONEXPO India is proud to join hands with the Construction Federation of India (CFI) for its 2024 edition News
  • Assam: Sarbananda Sonowal interacts with Students during ‘Parikhsa Pe Charcha’ programme in Nagaon News
  • Dr Rahul Karad Felicitated By Lok Sabha Speaker Om Birla At 11th Commonwealth Parliamentary Association Conference In Bengaluru India
  • The Requirements for Weight Loss Surgery: Understanding the Criteria News

Respiratory disease burden highest in India, COPD one of the fastest growing respiratory diseases: SMSRC

Posted on July 16, 2024 By No Comments on Respiratory disease burden highest in India, COPD one of the fastest growing respiratory diseases: SMSRC

New Delhi (India), July 16:   SMSRC & Group (Medclin Research and Synaegis), one of India’s leading healthcare research, intelligence & consulting organizations has published findings on major disease trends prevailing in India, and how they are currently being managed by healthcare providers. The study reveals that Diseases of the Respiratory System as the largest disease area in India.

The study was conducted on the basis of MAT Feb 2024 prescription audit – de identified and aggregated data, of more than 10,700 doctors over a 15-year period. Drs in the sample were distributed across all key specialties, across 80+ cities/towns of India. This is a first of its kind real world evidence-based study from an Indian context.

According to the publication, Diseases of the Respiratory System is the largest disease area in India, constituting 15.3% of all Rx of total patients with diseases in India. Endocrine & Metabolic diseases (e.g. Diabetes and others) is at second place with 13.5% share of Rx of all patients, followed by GI related diseases and circulatory diseases (hypertension, cholesterol etc) as the next ranked disease area.

Respiratory diseases that constitute of various upper/lower respiratory tract diseases, are treated via the following therapeutic class of medicines – antibiotics, cough & cold preparations, pain relievers and respiratory products. Respiratory products constituting of anti-asthma tablets, syrups, inhalers and nebulizer categories are one of the fastest growing therapeutic class of medicines in India. 

Further, within Diseases of the Respiratory System, URTI (Upper Respiratory Tract Infection) constitutes 27% of the share in 2024 and is the largest type of respiratory diseases. However, over the past 10 years COPD (Chronic Obstructive Pulmonary 

Disease) – 6% of all respiratory diseases) and “Running Nose” (an upper respiratory tract condition) have been the relatively faster growing respiratory diseases. COPD that is driven more by external environment (e.g. pollution, biomass fuel) & lifestyle driven factors (e.g. smoking, burning tobacco) has been the key disease driving the growth in respiratory diseases in India. COPD is predominantly an urban phenomenon with metro and tier 1 cities seeing approx. 90% cases, and its occurrence is majorly seen across male patients above 51 years. 

Specialist Dr segments such as Chest Physicians, Cardiologists, Diabetologists & Consulting Physicians treat COPD patients with anti – asthma solids, anti-asthma inhalers, & nebulization – in descending order of preference. Cough preparation and antibiotics are also used. As per the SMSRC report, since 2014 there has been a 1.3x growth in the usage of Anti-Asthma Inhalants + Nebulization, as compared to Anti Asthma tablets in the management of COPD. Inhalants/Nebulization generally considered a superior and more effective treatment choice, still has immense potential to continue to provide increasing relief to a growing number of COPD patients, given they are still the second ranked category to anti-asthma solids.

The incidence of Asthma, a more genetic condition contributing 10% of all respiratory diseases, has seen a more moderate increase over the past 10 years. Younger patients below 10 years constitute the largest chunk of asthmatic patients, although an increasing proportion of elderly patients are also seen being diagnosed with asthma as compared to 10 years ago (35% above 41 years of age in 2014 vs 41% above 41 years of age in 2024). 

Chest Physicians, Cardiologists, and Consulting Physicians generally prefer anti – asthma solids followed by inhalers/nebulizers. Since 2014, the growth in the usage of inhalers/nebulizers has been 1.2x, as compared to that of Anti Asthma tablets. However, inhalers are still second preference to anti-asthma tablets amongst Chest Physicians, Cardiologists and Consulting Physicians. Unlike COPD though, given the younger age cohort in asthmatic patients, Paediatricians are also an important segment but the usage of inhalers are much lesser, with anti-asthma tablets & syrups and cough preparation being a more preferred mode of treatment. 

Dr Sanjoy Mitra, Founder & MD of SMSRC mentions, “Given the inclination towards respiratory diseases in India, the general patient population is advised to maintain a better quality of lifestyle to help reduce the growing respiratory disease burden in the country. Authorities and policy makers could further strengthen controls on excessive pollution, whereas healthcare delivery stakeholders can focus on increasing both the depth (i.e., compliance) and spread (i.e., awareness to compliance) in the usage of the more effective treatment medication, such as inhalers in the management of COPD & Asthma in India.”

SMSRC plans to research further and support healthcare delivery stakeholders, on increasing both depth and spread of effective treatment methods amongst Drs/Patients for COPD & Asthma help reduce the disease burden.

If you have any objection to this press release content, kindly contact pr.error.rectification@gmail.com to notify us. We will respond and rectify the situation in the next 24 hours.

Related

News

Post navigation

Previous Post: Jane Dipika Garrett (Miss Universe 2023- Top 20): Steps into the Bollywood Industry?
Next Post: Udaipur’s Newest Gem: Eternal Handicrafts Opens Silver & German Silver Furniture Showroom

Related Posts

  • Tophawks appoints accomplished entrepreneur Yashaswi Priyadarshi as its new CEO News
  • Amid winter, with increased smog and pollution, informed healthcare decisions can be life-savers for respiratory disease patients News
  • “Be you, be original, don’t try to be one amongst the herd” says fashion & costume designer -Darshan Jalan & team News
  • New Zealand Welcomes New Year 2026 After Kiribati With Massive Fireworks At Sky Tower – WATCH VIDEOS India
  • Shah Rukh Khan, Amitabh Bachchan to be guests of honour at 28th Kolkata International Film Festival News
  • Mumbai’s No.1 Eye Surgeon Dr. Cyres K. Mehta Unveils Two Remarkable Books News

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

  • Art of Living
  • Arts
  • Auto & Transportation
  • Automobile
  • Aviation
  • Banking
  • BCA ELECTIONS 2026
  • Bollywood
  • Brands
  • Business
  • Business Technology
  • Commodities
  • Economy
  • Education
  • Energy
  • Entertain­ment & Media
  • Entertainment
  • Entrepreneurs
  • Environment
  • Financial Services & Investing
  • Fitness
  • Gadgets
  • Health
  • Housing & Infrastructure
  • India
  • Information Technology
  • International
  • International Education
  • Investment
  • Lifestyle
  • Narendra Modi
  • News
  • People & Culture
  • Pharma
  • Policy & Public Interest
  • Politics
  • Sports
  • Stock Market
  • Tamilnadu
  • Technology
  • Telecom
  • The Multitaskers: A Series On Entrepreneurship with difference.
  • Travel
  • Uncategorized
  • UNICEF
  • Wellness
  • World News

Recent Posts

  • RoYALS Garba Faces Outrage from Barodians: High Fees, No Parking — Visitors Clash with Security, Horns Blare in Protest as Gates Shut After 10 PM
  • Opposition to ring the Election Commission tomorrow: Congress maps a street-to-Parliament campaign through October and November
  • Cockroach Party to CEC: Quit in 48 Hours — or We Take the Fight Nationwide Over 13 Crore Deleted Voters
  • A Temple of Health and a ₹1-Lakh-Crore Bet: Bengal CM, Gautam Adani Break Ground on 2,000-Bed Arogya Mandir
  • Baroda’s Moliya Captains Rest of India U-23 for CK Nayudu Trophy Clash in Chennai

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • June 2026
  • May 2026
  • April 2026
  • March 2026
  • February 2026
  • January 2026
  • December 2025
  • November 2025
  • October 2025
  • September 2025
  • August 2025
  • July 2025
  • June 2025
  • May 2025
  • April 2025
  • March 2025
  • February 2025
  • January 2025
  • December 2024
  • November 2024
  • October 2024
  • September 2024
  • August 2024
  • July 2024
  • June 2024
  • May 2024
  • April 2024
  • March 2024
  • February 2024
  • January 2024
  • December 2023
  • November 2023
  • October 2023
  • September 2023
  • August 2023
  • July 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • January 2023
  • December 2022
  • November 2022
  • October 2022
  • September 2022
  • August 2022
  • July 2022
  • June 2022
  • May 2022
  • April 2022
  • October 2021
  • September 2021

  • Healing Hospital Chandigarh Named Best Private Hospital by Hon’ble Governor, Launches TB Support Initiative Brands
  • Leo Dryfruits & Spices Wins EIH Contract for Trident, Oberoi Hotels & Flight Services Mumbai Brands
  • Vani Prakashan Heralds Dharamvir Bharati’s Centenary With Star-Studded Fest Brands
  • Emerald Finance Reports Stellar 138% YoY Growth in Standalone Net Profit for Q1 FY26 Brands
  • TravelTech Ziptrrip Partners with PeopleStrong to Revolutionize Corporate Travel and Expense Management Brands
  • Indian AI startup Blinkit-AI Secures USD 1.2 Million in Funding to Scale Unified AI Services in India Brands
  • I.B.M.R., I.P.S. Academy Hosts International Management Conference on Sustainability and Innovation Brands
  • Miss & Mrs International – Woman of Substance 2025 Concludes in Dubai with Glamour & Grandeur Brands

Powered by PressBook News WordPress theme